Legal Representation
Attorney
Nancy Sabarra
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 24, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 17, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 16, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 26, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 26, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Nov 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 23, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 22, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 22, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 30, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 30, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 30, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 4, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 4, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 15, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 24, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 14, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 13, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 13, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 20, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 20, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 23, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 23, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 23, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 27, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 27, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 17, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 15, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development
Class 044
Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics
Additional Information
Design Mark
The mark consists of of the wording "CELLJUVANT STUDY" above the wording "CELL-BASED ADJUVANT TECHNOLOGY". Above the "J" in "CELLJUVANT" is a design of a circle with an arrow-like shape through the circle. The tip of the arrow is a design of a rocket ship. The "CELL" element of "CELLJUVANT" is in the color purple. The "JUVANT" element of "CELLJUVANT" and the word "STUDY" are in the color red. The rest of the wording in the mark is in the color gray. The circle element of the design is in the colors red and gray, and the arrow-like element of the design is red and purple with the rocket ship element being in the color purple.
Color Claim
The color(s) red, purple, and gray is/are claimed as a feature of the mark.
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"STUDY CELL-BASED ADJUVANT TECHNOLOGY"